Development of green production technology and research of harpagophytum procumbens root dry extract

Abstract

The aim of this work is to study of standardization parameters and pharmacological properties of Harpagophytum procumbens (H. procumbens) root dry extract.
 Materials and methods – obtaining of H. procumbens root dry extract was performed in accordance with developed scheme that is characterized by simplicity and cost-effectiveness of technology compared to analogous scheme. Study of standardization parameters of obtained extract was performed in accordance with the requirements of the monograph «Harpagophyti extractum siccum» of the State Pharmacopoeia of Ukraine 2.2., harmonized with the monograph «Harpagophyti extractum siccum» of the European Pharmacopoeia 9.5. Pharmacology study of analgesic and anti-inflammatory activities were conducted on the rat paw formalin-induced edema model.
 Results. Obtained H. procumbens root dry extract is a free flowing, non-hygroscopic, light brown powder with taste and odor that is specific to raw material of H. procumbens. Determined loss on drying was 3.2±0.18 %. Content of heavy metals in dry extract was not more than 0.01 % (100 ppm). Harpagoside was identified by TLC method. Chromatographic zones on the obtained chromatograms of the reference solution and test solutions are the same in intensity of a color, cross-over and sharpness of development. Based on the results of the research performed by HPLC method, it has been established that content of harpagoside in investigated H. procumbens root dry extract is 2.50±0.02 %.
 According to the results of pharmacological research it was found that investigated dry extract (the content of harpagoside is not less than 37.0 mg/kg) showed a higher activity compared to reference drug («Phong Te Thap»).
 Conclusions. A new method of obtaining dry extract of H. procumbens (3.5:1) was proposed. The developed green production technology is simple; it does not require special equipment and expensive solvents. A correspondence of quality parameters with the requirements of State Pharmacopoeia of Ukraine and European Pharmacopoeia: appearance, identification of harpagoside and fructose, loss of drying, content of heavy metals, assay of harpagoside (2.50±0.02 %) was set. Analgesic and anti-inflammatory activities of H. procumbens dry extract has been established

Development of Monodispersed Polystyrene Particles as Thailand Reference Materials (TRM)

“…CRMs are widely used for calibration of an apparatus, method validation, assessment of method and instrument performance, establishing traceability or the measurement results, and determining the uncertainty of these results [ 2 – 6 ]. They are the most appropriate choice for quality control activities.…”

The Fight against Infection and Pain: Devil’s Claw (Harpagophytum procumbens) a Rich Source of Anti-Inflammatory Activity: 2011–2022

“…These secondary tubers are 25 cm long with 6 cm thickness. The particular secondary roots are the therapeutic part of the plants as they consist of between 0.5 and 3% of iridoid glycosides [ 30 , 42 ]. The leaves are borne on opposite sides of the trailing stem, and they are irregularly divided into 3–5 lobes while being greyish-green in colour because of the tiny whitish mucilage cells covering them as shown in Figure 2 A.…”

The Therapeutic Potential of Harpagophytum procumbens and Turnera subulata and Advances in Nutraceutical Delivery Systems in Neurodegenerative Diseases

“…This analgesic effect is related to the production of COX-2 and prostaglandin E2 (PGE2), along with the inhibition of prostaglandin synthesis [17,25,26]. Therefore, for individuals suffering from conditions such as osteoarthritis, harpagosides, particularly harpagoside, and harpagide, play a crucial role in modifying pain perception and, thus, improving the clinical condition of patients [27,28].…”